Cargando…
Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
Neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and frontotemporal dementias (FTD), are considered distinct entities, however, there is increasing evidence of an overlap from the clinical, pathological and genetic points of view. All neurodegenerative diseases...
Autores principales: | Grasso, Margherita, Piscopo, Paola, Confaloni, Annamaria, Denti, Michela A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271879/ https://www.ncbi.nlm.nih.gov/pubmed/24858274 http://dx.doi.org/10.3390/molecules19056891 |
Ejemplares similares
-
A Sex Perspective in Neurodegenerative Diseases: microRNAs as Possible Peripheral Biomarkers
por: Piscopo, Paola, et al.
Publicado: (2021) -
Identification of miRNAs regulating MAPT expression and their analysis in plasma of patients with dementia
por: Piscopo, Paola, et al.
Publicado: (2023) -
Reduced miR-659-3p Levels Correlate with Progranulin Increase in Hypoxic Conditions: Implications for Frontotemporal Dementia
por: Piscopo, Paola, et al.
Publicado: (2016) -
Statistical analysis of a Bayesian classifier based on the expression of miRNAs
por: Ricci, Leonardo, et al.
Publicado: (2015) -
Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases
por: Gentile, Giulia, et al.
Publicado: (2022)